Open AccessDiabetic macular edema: Current and emerging therapies
Author(s) -
Adam S. Wenick,
Neil M. Bressler
Publication year - 2012
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.92110
Subject(s) - medicine , diabetic macular edema , macular edema , ophthalmology , clinical trial , edema , pathogenesis , diabetes mellitus , diabetic retinopathy , intensive care medicine , optometry , surgery , visual acuity , endocrinology
Diabetic macular edema is a leading cause of vision impairment among people within the working- age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photocoagulation, intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents. The biologic rationale for novel therapeutic agents, many of which are currently being evaluated in clinical trials, also is reviewed.